VEGFC and urinary bladder cancer: EV-packaged BCYRN1 secreted by bladder cancer cells epigenetically increases WNT5A expression, thereby facilitating VEGF-C secretion, and forms an WNT5A/VEGF-C/VEGFR3 feedforward loop that enhances lymphangiogenesis6.